Daily Dose of Global Truth.
A personalised neoantigen vaccine combined with nivolumab was feasible and acceptably safe in a phase 1 ovarian cancer trial, researchers…
WhatsApp us
Sign in to your account
Username or Email Address
Password
Remember Me